Mariagrazia Felisi

Author PubWeight™ 6.63^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients.	Br J Haematol	2002	1.21
2	Assessment of pediatric asthma drug use in three European countries; a TEDDY study.	Eur J Pediatr	2010	1.19
3	Defining off-label and unlicensed use of medicines for children: results of a Delphi survey.	Pharmacol Res	2008	1.08
4	Risk factors for death in patients with beta-thalassemia major: results of a case-control study.	Haematologica	2006	0.93
5	Pharmacotherapy of iron overload in thalassaemic patients.	Expert Opin Pharmacother	2003	0.91
6	Effects of safety warnings on prescription rates of cough and cold medicines in children below 2 years of age.	Br J Clin Pharmacol	2011	0.84
7	The management of iron chelation therapy: preliminary data from a national registry of thalassaemic patients.	Anemia	2011	0.83
8	Safety Profile of Oral Iron Chelator Deferiprone in Chinese Children with Transfusion-Dependent Thalassaemia.	Curr Drug Saf	2016	0.75